pathwayRes	pathway	pathwayTitle	GenesInPWs
<https://identifiers.org/wikipathways/WP129_r117774>	WP129	Matrix metalloproteinases	1
<https://identifiers.org/wikipathways/WP1423_r117518>	WP1423	Ganglio sphingolipid metabolism	2
<https://identifiers.org/wikipathways/WP1772_r120736>	WP1772	Apoptosis modulation and signaling	2
<https://identifiers.org/wikipathways/WP183_r117060>	WP183	Proteasome degradation	1
<https://identifiers.org/wikipathways/WP185_r116785>	WP185	Integrin-mediated cell adhesion	1
<https://identifiers.org/wikipathways/WP2289_r120498>	WP2289	Drug induction of bile acid pathway	1
<https://identifiers.org/wikipathways/WP23_r120701>	WP23	B cell receptor signaling pathway	1
<https://identifiers.org/wikipathways/WP2328_r120805>	WP2328	Allograft rejection	1
<https://identifiers.org/wikipathways/WP2374_r120781>	WP2374	Oncostatin M signaling pathway	1
<https://identifiers.org/wikipathways/WP24_r113974>	WP24	Peptide GPCRs	1
<https://identifiers.org/wikipathways/WP2572_r119251>	WP2572	Primary focal segmental glomerulosclerosis (FSGS)	1
<https://identifiers.org/wikipathways/WP2840_r120866>	WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	3
<https://identifiers.org/wikipathways/WP2858_r116763>	WP2858	Ectoderm differentiation	1
<https://identifiers.org/wikipathways/WP2864_r108133>	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1
<https://identifiers.org/wikipathways/WP2877_r119905>	WP2877	Vitamin D receptor pathway	2
<https://identifiers.org/wikipathways/WP2878_r116507>	WP2878	PPAR-alpha pathway	1
<https://identifiers.org/wikipathways/WP2879_r116462>	WP2879	Farnesoid X receptor pathway	1
<https://identifiers.org/wikipathways/WP2880_r117734>	WP2880	Glucocorticoid receptor pathway	1
<https://identifiers.org/wikipathways/WP2882_r120815>	WP2882	Nuclear receptors meta-pathway	3
<https://identifiers.org/wikipathways/WP299_r117807>	WP299	Nuclear receptors in lipid metabolism and toxicity	1
<https://identifiers.org/wikipathways/WP3301_r120029>	WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1
<https://identifiers.org/wikipathways/WP3591_r88424>	WP3591	Sleep regulation	1
<https://identifiers.org/wikipathways/WP3594_r117682>	WP3594	Circadian rhythm genes	1
<https://identifiers.org/wikipathways/WP3617_r106541>	WP3617	Photodynamic therapy-induced NF-kB survival signaling	1
<https://identifiers.org/wikipathways/WP3658_r116670>	WP3658	Wnt/beta-catenin signaling pathway in leukemia	1
<https://identifiers.org/wikipathways/WP382_r119087>	WP382	MAPK signaling pathway	1
<https://identifiers.org/wikipathways/WP383_r118423>	WP383	Striated muscle contraction pathway	1
<https://identifiers.org/wikipathways/WP3893_r118859>	WP3893	Development and heterogeneity of the ILC family	1
<https://identifiers.org/wikipathways/WP3958_r117148>	WP3958	GPR40 pathway	1
<https://identifiers.org/wikipathways/WP4142_r119292>	WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1
<https://identifiers.org/wikipathways/WP4217_r120623>	WP4217	Ebola virus infection in host	2
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	1
<https://identifiers.org/wikipathways/WP4389_r116629>	WP4389	Bile acids synthesis and enterohepatic circulation 	1
<https://identifiers.org/wikipathways/WP4396_r98945>	WP4396	Nonalcoholic fatty liver disease	1
<https://identifiers.org/wikipathways/WP4481_r121702>	WP4481	Resistin as a regulator of inflammation	1
<https://identifiers.org/wikipathways/WP455_r117740>	WP455	GPCRs, class A rhodopsin-like	1
<https://identifiers.org/wikipathways/WP4584_r119306>	WP4584	Biomarkers for pyrimidine metabolism disorders	1
<https://identifiers.org/wikipathways/WP4656_r120396>	WP4656	Joubert syndrome	1
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	1
<https://identifiers.org/wikipathways/WP4754_r115147>	WP4754	IL-18 signaling pathway	2
<https://identifiers.org/wikipathways/WP4917_r119111>	WP4917	Proximal tubule transport	2
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	1
<https://identifiers.org/wikipathways/WP4971_r122106>	WP4971	Phosphoinositides metabolism	1
<https://identifiers.org/wikipathways/WP5044_r119244>	WP5044	Kynurenine pathway and links to cell senescence	1
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	2
<https://identifiers.org/wikipathways/WP5083_r120385>	WP5083	Neuroinflammation and glutamatergic signaling	2
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	1
<https://identifiers.org/wikipathways/WP5095_r120801>	WP5095	Overview of proinflammatory and profibrotic mediators	1
<https://identifiers.org/wikipathways/WP5110_r120392>	WP5110	Familial hyperlipidemia type 3	1
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	1
<https://identifiers.org/wikipathways/WP5115_r120811>	WP5115	Network map of SARS-CoV-2 signaling pathway	1
<https://identifiers.org/wikipathways/WP5166_r122169>	WP5166	Glyoxylate metabolism	1
<https://identifiers.org/wikipathways/WP5176_r122283>	WP5176	Disorders of bile acid synthesis and biliary transport	1
<https://identifiers.org/wikipathways/WP5188_r122585>	WP5188	Retinol metabolism	1
<https://identifiers.org/wikipathways/WP5190_r122630>	WP5190	Creatine pathway	1
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	1
<https://identifiers.org/wikipathways/WP673_r118930>	WP673	ErbB signaling pathway	1
<https://identifiers.org/wikipathways/WP702_r106643>	WP702	Metapathway biotransformation Phase I and II	1
<https://identifiers.org/wikipathways/WP710_r116542>	WP710	DNA damage response (only ATM dependent)	1
